{"nct_id":"NCT03047395","title":"A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )","status":"COMPLETED","status_verified_date":"2024-11","start_date":"2017-02-27","start_date_type":"ACTUAL","primary_completion_date":"2023-11-29","primary_completion_date_type":"ACTUAL","completion_date":"2023-11-29","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ABBV"]}